VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2022 | Clinical trial updates in CML

Timothy Hughes, MD, FRACP, FRCPA, South Australian Health and Medical Research Institute (SAHMRI), Adelaide, Australia, discusses two clinical trials investigating treatment approaches in chronic myeloid leukemia (CML). Prof. Hughes first highlights the ASCEMBL trial (NCT03106779) comparing the use of asciminib versus bosutinib and reports on the two-year data from this trial. Prof. Hughes then comments on a Canadian study investigating treatment approaches in patients rwhere disease progression was observed whilst taking imatinib. This interview took place at the European Hematology Association (EHA) Congress 2022 held in Vienna, Austria.

Disclosures

Ad boards and research support from Novartis and Takeda

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter